Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

Clinical trial NCT03988205 · TERMINATED

Trial details

NCT number: NCT03988205
Sponsor: Medical College of Wisconsin
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2019-08-28
Primary completion: 2021-12-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.